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Background. Measles caused mortality in .164,000 children in 2008, with most deaths occurring during
outbreaks. Nonetheless, the impact and desirability of conducting measles outbreak response immunization (ORI)
in middle- and low-income countries has been controversial. World Health Organization guidelines published in
1999 recommended against ORI in such settings, although recently these guidelines have been reversed for countries
with measles mortality reduction goals.
Methods. We searched literature published during 1995–2009 for papers reporting on measles outbreaks.
Papers identiﬁed were reviewed by 2 reviewers to select those that mentioned ORI. World Bank classiﬁcation of
country income was used to identify reports of outbreaks in middle- and low-income countries.
Results. We identiﬁed a total of 485 articles, of which 461 (95%) were available. Thirty-eight of these papers
reported on a total of 38 outbreaks in which ORI was used. ORI had a clear impact in 16 (42%) of these outbreaks.
In the remaining outbreaks, we were unable to independently assess the impact of ORI.
Conclusions. These ﬁndings generally support ORI in middle- and low-income countries. However, the
decision to conduct ORI and the nature and extent of the vaccination response need to be made on a case-by-case
basis.
Measles was estimated to cause mortality in .164,000
children in 2008 [1], with most cases and deaths oc-
curring during the course of outbreaks. It is a highly
infectious,frequently seasonalviraldisease characterized
in settings of endemicity by epidemics of multiyear
periodicity. Respiratory droplets carrying virus spread
from infected individuals to susceptible hosts’ re-
spiratory tract epithelial cells. A 10–14 day incubation
period occurs between infection and symptom onset;
during this period, viral replication occurs ﬁrst in re-
spiratory tract epithelial cells, followed in sequence by
replication in local lymphatic tissue, viremia, and viral
spread to organs. Viral replication occurs in macro-
phages, lymphocytes, and monocytes and in epithelial
and endothelial cells [2]. To stop virus transmission,
population immunity of 95% is generally considered
to be necessary [3]. Measles is associated with case-
fatalityratios of 2%–15%in developingcountries [4]. In
emergency settings, case-fatality ratios as high as 30%
havebeenreported[5].For .45years,a cheap,safe, and
highly efﬁcacious measles vaccine has existed. Anti-
bodies to measles appear 12–15 days after vaccination,
peaking 20–28 days later [6]. Vaccination within 72 h
after exposure to measles virus has been shown to result
in prevention or decreased severity of disease [7–10].
Despite global progress in measles control since 2000,
measles remains endemic in many countries. Even in
areas where measles is no longer endemic, outbreaks of
varying magnitude have occurred. Although the im-
portance of conducting outbreak response immuniza-
tion (ORI) in emergency situations has been well
recognized and accepted [11, 12], the impact and de-
sirability of conducting measles ORI, particularly mass
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 vaccination campaigns, in middle- and low-income countries
has been controversial [13]. This controversy was in part a re-
sponse to Aylward’s 1997 manuscript entitled ‘‘The Impact of
Immunization Control Activities on Measles Outbreaks in
Middle and Low Income Countries.’’ This review found 17
papers published during 1977–1993 that reported on 13 out-
breaks with ORI. Aylward concluded that ‘‘The data that are
available.suggest that outbreak immunization activities in
developing countries do not have signiﬁcant impact on the
course of measles epidemics.Immunization activities did not
begin until well after the onset of the outbreaks, by which time
the measles virus had probably spread widely.’’ [14]. In 1999,
the World Health Organization (WHO) stated that ‘‘the im-
munization response in most outbreaks occurs too late to affect
the impact of the outbreak.Supplementary vaccination activ-
ities (SVAs) in the course of an outbreak are not recommended
unless there is substantial political or community pressure.If
implemented, SVAs should focus on unaffected areas where the
epidemic is.likely to spread’’ [15, pp. 6, 7]. However, in 2009,
these guidelines were revised to provide guidance to countries
with a measles mortality reduction goal and recommended ORI
in certain situations. The reasons for this revision are clearly and
succinctly stated as follows:
d The expanded use of a second opportunity for measles
immunization through nationwide mass-vaccination cam-
paigns in high burden countries has resulted in marked re-
ductions in measles incidence associated with reduced
community acceptance of large outbreaks.
d Endorsement oftheInternationalHealthRegulations (2005)
highlighted the importance of timely detection and response to
events that are of potential international public-health concern.
d Recent literature on the impact of outbreak response im-
munization found measles epidemics in endemic, pre catch-up
supplementary immunization activity (SIA) settings can last 3-9
months providing adequate time to mount a focused, high
quality campaign [16, p. 2].
A portion of the literature review summarized in this article
was presented at a WHO meeting held in consideration of re-
vising the previous guidelines, and 2 of the authors (KLC and
RFG) served as expert reviewers for the 2009 guidelines.
More than 15 years have elapsed since the publication of the
last article reviewed by Aylward, and more than a decade since
the publication of Aylward’s article. Over this period, the status
of global measles control has changed dramatically; the Amer-
icas have seen the elimination of indigenous measles [17, 18],
and 4 of the 5 remaining WHO Regions have time-limited
measles elimination goals. Worldwide, measles-associated
deaths are estimated to have decreased by 78% in 2008, com-
pared with 2000 [1]. This decrease in measles is attributed to
an emphasis on increasing routine immunization coverage,
offering a second dose of measles vaccine to all children
either through routine immunization services or periodically
through supplemental immunization activities (SIAs),
strengthening measles surveillance, and improving measles
case management [1, 19]. Relative to the 1980s and 1990s,
many countries now have increased political commitment to
measles control, more timely measles surveillance, national
experience with high-coverage SIAs, and smaller, less frequent
measles outbreaks [20, 21].
In this context, we wished to reassess the potential impact of
mass campaigns to control measles outbreaks in middle- and
low-income countries as documented in the more recently
published literature. This impact could be determined either at
the individual level (eg, the decrease in severity of disease among
vaccinatedcases)oratthepopulationlevel,atwhichdecreasesin
incidence and transmission might be measured. ORI was clas-
siﬁed as selective (ie, targeting only those without evidence of
vaccination) or nonselective (ie, targeting all in a selected age
group regardless of vaccination status).
METHODS
WesearchedPubMed/MEDLINE,EMBASE,LatinAmericanand
Caribbean Center on Health Sciences Information, Index Med-
icus for the Eastern Mediterranean Region, and African Index
Medicus for articles published from 1 January 1995 through 3
July 2009 in English, French, Italian, Portuguese, or Spanish. We
searched PubMed/MEDLINE and EMBASE using the key words
‘‘measles’’ and ‘‘outbreak’’ or ‘‘outbreaks’’ or ‘‘epidemic’’ or
‘‘epidemics.’’ In the remaining databases, separate searches were
done using the keyword ‘‘measles.’’ The results of all searches
were reviewed to identify and remove articles that did not report
on a measles outbreak in humans. (Measles is primarily asso-
ciated with outbreaks in humans, but has also been reported in
outbreaks among nonhuman primates.) Papers were then
obtained, reviewed by 2 reviewers, and categorized as relevant
or not relevant; the bibliographies of the papers were also
reviewed for additional citations. Any article that mentioned
the use of ORI was considered to be relevant. ORI was con-
sidered to be any immunization with measles-containing
vaccine beyond routine services in response to an increase in
measles cases. Any discrepancy between reviewers with regard
to the relevancy of papers reviewed was resolved through
discussion. All articles considered to be relevant were classi-
ﬁed according to the World Bank designation [22] of the
outbreak country’s income level for the year during which the
outbreak occurred. For the purposes of this article, we con-
sidered only articles reporting on outbreaks in middle- or
low-income countries, based on the World Bank designation.
Aylward’s article, published in 1997, fell within the period of
our search. However, because his article was a review of articles
published before 1995 and because our goal was to discover
what more recent data showed, we did not include in our
analysis any of the historical outbreaks that he described.
S36 d JID 2011:204 (Suppl 1) d Cairns et al
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 RESULTS
We identiﬁed a total of 485 articles through our search strategy.
We were able to obtain 461 (95%) of these articles; the 24 that
we were unable to obtain were from journals not published or
accessible in the United States or were theses or technical reports
archived in libraries not located in the United States. Of these
461 articles, 38 reported on 38 outbreaks in which ORI was used
and that occurred in middle- or low-income countries. Some
articles described .1 outbreak, whereas in other instances
multiple papers described the same outbreak. We attempted to
determine objectively the impact of ORI on the basis of the data
provided (Table 1).
During the period considered, WHO Regions varied sub-
stantially in their approaches to, goals for, and extent of measles
control. Because we believed that these characteristics might
affect the use and impact of ORI, the articles discussed below are
grouped by region. Table 1 provides a comprehensive listing of
outbreaks in which ORI was used.
Western Pacific Region
Two papers reported on outbreaks in Papua New Guinea
[23, 24]. Mgone et al [23] described 314 cases that were part of
a 1999 epidemic occurring in an area with only 8% routine
coverage. Control measures included ‘‘ﬂying vaccination clin-
ics’’ (the authors do not describe exactly what is meant by this)
to reach remote communities, and a mass vaccination cam-
paign. Of these patients, 126 (40%) had received at least 1
vaccine doseaccording tothe childhealthrecordbook,although
32 were vaccinated when they were ,6 months of age and 44
were vaccinated ,14 days before rash onset. Children vacci-
nated .14 days before rash onset had a decreased risk of
complications (P , .001) and of death (P 5 .067); the authors
claim that most of these children received vaccination during
ORI.
Six papers described outbreaks of measles in Micronesia,
islands where measles vaccination coverage ranged from
55%–94%. During 1991–1994, outbreaks of measles moved
through this area, ultimately totaling 1353 cases in a population
of 300,000 [25, 26]. With the exception of Guam, the out-
breaks were the ﬁrst in these islands in 20 years. All islands
except Guam conducted mass vaccination campaigns targeting
all children aged R6 months who had been born since the last
outbreak; Guam targeted all children aged 6–59 months. In
a simple linear regression analysis, time to reach 80% coverage
of the target population was signiﬁcantly associated with
duration of outbreaks (b coefﬁcient 5 .82; P 5 .026), and size
of population was positively associated with and time since
last outbreak was inversely associated with (P values not given
in paper) duration of the outbreak; however, these associations
were not statistically signiﬁcant (P . .05). The time required
to vaccinate 80% of the population remained signiﬁcantly
associated with the duration of the outbreak, even when con-
trolling for routine measles vaccination coverage in a stepwise
linear regression model (P 5 .049) [25].
Theaforementioned1994measlesoutbreaksdidnotaffectthe
Marshall Islands. However, during July–November 2003, after
15 measles-free years, these Micronesian atolls experienced an
outbreak with 826 cases in patients aged 2 weeks through 43
years [27–30]; 92% of patients were from the densely populated
capital of Majuro. In late August, a mass vaccination campaign
targeting children aged 6 months through 15 years who did not
have written evidence of 2 doses of measles-mumps-rubella
vaccine was implemented. Because more cases were found in
older age groups, the target age group for the campaign ex-
panded to include patients aged ,40 years and the campaign
continued through October, ultimately leading to 93% 1-dose
coverage inthose aged6 monthsthrough40years.Transmission
stopped shortly after vaccination activities were concluded. The
articles describing this outbreak detail the vaccination activities
conducted but do not comment directly on the impact of the
ORI. Assessing the impact of this activity is particularly difﬁcult,
because it was conducted over many weeks and the population
was too small to sustain endemic transmission of measles.
Two articles described outbreaks with ORI in Fiji [31, 32].
However, detailed information on ORI and its impact were only
available for the 2006 outbreak. In February 2006, Fiji reported
the ﬁrst laboratory-conﬁrmed measles casessince 1998. From 17
February through 9 June, a total of 132 suspected measles cases
were reported. Children aged 6 months to ,6 years were tar-
geted for ORI, an activity that began 6 weeks after the ﬁrst case
was reported. By 24 May, 98% of targeted children had been
vaccinated. No patients with rash onset after 21 May were re-
ported. The response to ORI was likely attributable to the rel-
ative rapidity of the response and the high coverage obtained.
The Eastern Mediterranean Region
Two papers reported outbreaks in Saudi Arabia [33] and Sudan
[34]. Al Wahaibi et al [33] described a school-based study in
Riyadh City, Saudi Arabia, where during October 1996–June
1997, 482 cases of measles were reported from 103 schools. In
response, school health units nonselectively vaccinated students
with measles-mumps-rubella. In the 14 schools able to vaccinate
all students, the authors state that vaccination within 10 days
after onset of the ﬁrst case resulted in a preventable fraction.
(Preventable fraction (PF) is deﬁned as PF 5 (I0 –I T)/I0 where
I0 5 rate in the population without intervention and IT 5 rate
in the population with intervention) of 59.5%, compared
with 2.1% in schools that delayed vaccination for R19 days.
In early 2004,measles cases were reported among populations
displaced by conﬂict in western Sudan. Among these pop-
ulations, background measles coverage was estimated to be
46%–77%. ORI targeting children aged 9–59 months was con-
ducted in camps and neighboring communities; current and
Outbreak Response Immunization for Measles d JID 2011:204 (Suppl 1) d S37
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 Table 1. Outbreaks in Which Outbreak Response Immunization Was Reported (n 5 38)
a,b
Region/Country [REF] Time to ORI
Selective or
nonselective
c Target area Target age Doses/Coverage
Author’s reported
impact
Documented impact
(our assessment)
Number of
outbreaks
a
Western Paciﬁc
PNG [23] ORI1: 9mo after 1
st
case
Nonselective Flying clinics in
2 districts
4mo–14y 2,000 Demonstrates that
vaccination before
rash onset results in
decreased mortality &
morbidity
Yes, basedondecreased
mortality & morbidity
assuming claim that
most vaccinated
cases were vaccinated
during ORI
1
ORI2: 14mo after 1
st
case
Nonselective Province 4mo–NR NR
PNG [24] N/A Selective Hospital Children 5558 NR Unclear 1
Micronesia [25, 26]
(Kosrae, Palau,
Saipan, Guam,
Pohnpei, Chuuk)
Various Nonselective Multiple
islands
Various Various Yes, time required to
vaccinate 80% of
popn signiﬁcantly
associated with o/b
duration. Size of popn
positively associated
with o/b duration, time
since last o/b & 1 dose
coverage inversely
associated [24]
Yes, based on data
presented regarding
signiﬁcance of time
to achieve 80%
coverage
6
Marshall Islands
[27, 28, 29, 30]
ORI1: 3wk after 1
st
case
Selective Outer islands
and schools
6mo–15y NR NR Yes, based on .50%
reduction in cases 21d
after 80% coverage
reached in target popn
1
ORI2: 6wk after 1
st
case
Selective Two major
islands
6mo–40y .93%
Fiji [31] 2mo Nonselective Island-wide
(Koro Island)
1–5y NR NR Unclear 1
Fiji [32] 6wk NR Island-wide 6mo–6y 98% Last case was reported
8w after ORI
Yes, based on rapid
increase in coverage
and decrease in cases
1
Eastern Mediterranean
Saudi Arabia [33] 14d median from 1
st
case
Nonselective 54 schools
in Riyadh
School aged
children
14 fully
vaccinated
schools
Report ORI effective
if done promptly:
Reported vaccination
within 10d of 1st case
resulted in a
preventable fraction
(PF) of 59%;
vaccination .19d after
1
st case resulted
in PF of 2.1%
Yes, based on data
presented on prevent-
able fraction
1
S
3
8
d
J
I
D
2
0
1
1
:
2
0
4
(
S
u
p
p
l
1
)
d
C
a
i
r
n
s
e
t
a
l
 
a
t
 
C
D
C
 
P
u
b
l
i
c
 
H
e
a
l
t
h
 
L
i
b
r
a
r
y
 
&
 
I
n
f
o
r
m
a
t
i
o
n
 
C
e
n
t
e
r
 
o
n
 
A
u
g
u
s
t
 
2
6
,
 
2
0
1
1
j
i
d
.
o
x
f
o
r
d
j
o
u
r
n
a
l
s
.
o
r
g
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 Table 1. (Continued)
Region/Country [REF] Time to ORI
Selective or
nonselective
c Target area Target age Doses/Coverage
Author’s reported
impact
Documented impact
(our assessment)
Number of
outbreaks
a
Sudan [34] ORI1: NR Nonselective IDP camps 9mo–5y 80,000 Reported that ORI
decreased morbidity &
mortality
Yes, . 50% reduction in
cases21dafterregion-
wide ORI
1
ORI2: 12wk Nonselective Region-wide 9mo–15y 77%
Americas
Mexico [35] NR Selective 70,000
surrounding
households
6mo–39y NR NR Unclear 1
Mexico [36] NR Nonselective 6y–11y, high
risk groups
10 million NR Unclear 3
Bolivia [37, 38] ORI1: 1998 4mo
after 1
st case
Nonselective Nationwide ,5y 85% Persistent o/b Yes, after multiple
immunization
activities
1
ORI2: 1999 NR House-to-house
Nationwide
,5y in most
places;
,15y in areas
of Amazon
98% Persistent o/b
ORI3: 2000 NR House-to-house ,5y 95% Transmission stopped
Haiti [39] ORI1: ,4wk after
1
st case
Nonselective Provincial city 6mo–14y 95% No cases in city within
2w of end of
campaign; spread to
rest of island
Yes, after multiple
activities
1
ORI2: NR Nonselective Departments 6mo–14y 65–95% No cases after early
August in department
ORI3: 5-9/00 Nonselective Port-au-Prince 6mo–14y 82%
ORI4: 11/00-1/01 Nonselective Port-au-Prince
neighborhood
6mo–14y 80 - 90% Reduced number of
cases island-wide
ORI5: 9-12/01 Nonselective Nationwide NR .85% Measles transmission
interrupted
Venezuela [40] NR Nonselective Statewide 1–14y NR Reported to end o/b Unclear 1
Venezuela [40] ORI1: 1mo after 1
st
case
Nonselective Nationwide ,5y 16/24 states
report .100%
Persistent o/b Yes, transmission
eventually stopped
1
ORI2: 4mo after 1
st
case
Nonselective Nationwide 6mo–14y
& high risk
adults
NR Epi curve shows impact
Colombia [40, 41] NR Nonselective Nationwide 6mo–5y
& high risk
groups
73% o/b ongoing when
MMWR published
Unclear 1
Chile [42] NR Nonselective Community-
wide
Contacts;
,1y &
20–40y
NR Reported to restrict o/b Unclear 1
Argentina [43, 44] NR ‘‘bloqueo’’ NR NR Reported to restrict
o/b [39]
Unclear 2
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 Table 1. (Continued)
Region/Country [REF] Time to ORI
Selective or
nonselective
c Target area Target age Doses/Coverage
Author’s reported
impact
Documented impact
(our assessment)
Number of
outbreaks
a
Peru [45] NR Nonselective Community-
wide
6mo–15y NR Reported no cases 3w
after ORI; 55%
susceptibles claimed
to be protected by
ORI; authors claim
that impact of ORI 36d
after 1
st case
attributable to large
percentage of
susceptibles in child &
adult popn & distance
between houses
slowing spread
Yes 1
African
Burkina Faso [46] ORI1: 26 wk after
1
st case
Nonselective Province Daycare &
primary
schools
98% Reported that impact
hard to determine
Unclear 1
ORI2: approx 37 wk
after 1
st case
NR ,15y catch
up
NR
Chad [49] 22wk after 1
st case Nonselective N’Djamena 6–59mo 81% ORI occurred very
late in the o/b
Unclear 1
Kenya [21] ORI1: 7mo NR 16 most
affected
districts
9–59mo 120% NR Unclear 1
ORI2: 10mo NR 62 remaining
districts
9–59mo 110%
Niger [13, 47, 48, 49, 50] 24wk after 1
st case Nonselective Niamey targeting
50% of target
age
6–59mo 57% of
target age
children
Median of 7.6%
(4.9–8.9) cases were
potentially averted
because of ORI [46]
;
Spatial-temporal
spreadofo/b suggests
targeted interventions
could have further
impacted [47]; 50% of
children with no prior
measles vaccination
received 1
st dose
during the ORI [49];
ORI occurred very late
in the o/b [48];If
conducted earlier,
likely that many cases
would have been
averted [12]
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 Table 1. (Continued)
Region/Country [REF] Time to ORI
Selective or
nonselective
c Target area Target age Doses/Coverage
Author’s reported
impact
Documented impact
(our assessment)
Number of
outbreaks
a
Zimbabwe [51] NR Selective NR NR Reported CFR directly
correlated with time to
recognition of o/b;
authors speculate that
this is due to inability
to vaccinate
susceptibles as rapidly
in these situations
Unclear 1
Southeast Asian
Sri Lanka [52] NR Nonselective Refugee camps,
welfare
centers,
preschools,
& slums
Children NR NR Unclear 1
India [53] Soonaftero/b began Nonselective Neighborhood ,5y NR Reported impact
hard to discern
Unclear 1
India [54] Soonaftero/b began Nonselective Neighborhood NR NR NR Unclear 1
India [55] 1 day before (SIAs
initiated because
of tsunami)
Nonselective All tsunami-
affected areas
6-60mo 117% Not able to document
impact of SIA, but
possibly limited
spread & responsible
for rapid decrease in
incidence
Unclear 1
European
Bulgaria [56] 5wk Selective Affected admin
regions
13mo-30y w/o
2 doses
MMR
Ongoing NR Unclear 1
Serbia [57] NR NR Contacts
6mo-25y &
children
1–15y not
previously
vaccinated
NR NR Unclear 1
Turkey [58] NR Nonselective Homes not yet
affected by o/b
Children 123 children NR Unclear 1
NOTE. NR, not reported; d, day; wk, week; mo, month; y, year; o/b, outbreak; popn, population.
a Some outbreaks were reported in multiple papers, while some papers report multiple outbreaks.
b In some cases, multiple rounds of ORI were conducted. In this table, each round is designated by a number.
c ‘‘Nonselective’’ indicates vaccination of all children in target age group regardless of prior disease or immunization status; ‘‘selective’’ indicates vaccination of children in target age who do not have written records of
having already received a pre-determined number of vaccine doses.
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 incoming residents of camps were also vaccinated. However,
transmission persisted. In response, a region-wide measles
campaign targeting children aged 9 months to 15 years was
conducted; this reached 93% of the accessible but only 77% of
the total target population. Although cases continued to occur,
the epidemiologic curve suggests that the mass campaign greatly
reduced transmission. Further evidence of the impact of ORI is
the fact that the lowest ORI coverage (44%) was in West Darfur,
whereas 51%ofcasesreportedafterthecampaignwere fromthis
area. In contrast, in South Darfur, ORI coverage was 97% and
only 12% of all cases reported after the SIA were inpatients from
South Darfur.
The Americas
Thirteen papers described outbreaks in Latin America. Santos
et al [35] reported on a Mexican outbreak that occurred in 2000.
Since 1999, Mexico has maintained measles vaccine coverage of
.95% in children aged 1–10 years. In 2000, 30 measles cases
werereportedfromMexicoCityand3states;inresponse,70,000
households were visited with vaccination of children aged 6–11
months and adults aged 15–39 years at risk of exposure. In 2003,
Mexicoexperienced44casesofmeaslesin3transmissionchains;
10 million children were then vaccinated, as were groups at high
risk of transmission [36]. However, the temporal relationship
between case detection and vaccination activities is not clear in
these reports. It is also difﬁcult to determine whether the limited
spread of measles was attributable to ORI or to the very high
existing background coverage.
During 1998–2001, Bolivia experienced a nationwide out-
break comprising almost 2500 cases [37, 38]. This outbreak
came several years after a nationwide ‘‘catch-up’’ campaign in
1994 and 3 years withfew reportedcases; during 2 of these years,
routine coverage fell by ,90%. (The measles elimination
strategy used in most countries of the Americas includes ‘‘catch-
up’’ campaigns targeting all children aged 9 months–14 years
designed to eliminate measles susceptibles, ‘‘keep-up’’ vaccina-
tion which entails reaching high vaccination coverage through
routine services, and periodic ‘‘follow-up’’ campaigns targeting
all children born since the last campaign). In May 1998, the ﬁrst
cases of the epidemic were reported in Yacuiba. In response,
vaccination was conducted in Yacuiba and other major cities;
however,casescontinued tobereported. Tohalttransmission of
measles, 3 nationwide campaigns were conducted in Bolivia in
October 1998, during November–December 1999, and during
September–December 2000 that targeted children aged ,5
years; the campaign in 1999 expanded the upper target age to 14
years in rural settings. In2002, nomeasles cases were reportedin
the country [37].
Haiti also conducted a nationwide catch-up campaign in
1994. This campaign was followed by 6 measles-free years, de-
spite a mean routine vaccination coverage of only 47% among
children aged 1 year. In 1999, a follow-up campaign was done,
but estimated coverage was only 70%–80% of the target pop-
ulation. In March 2000, measles was conﬁrmed in the Haitian
city of Gonaı ¨ves. In response, a door-to-door vaccination
campaign was rapidly done in the city targeting children aged 6
months to 15 years and reportedly achieving 95% coverage.
Within 2 weeks after its completion, no further measles cases
were reported from the city. However, measles had spread to
nearby cities and to the capital of Port-au-Prince. Measles
transmission was halted by the end of August in the department
surrounding Gonaı ¨ves after additional door-to-door ORI cam-
paigns. In Port-au-Prince, a vaccination campaign targeting
children aged 6 months to 15 years achieved only moderate
coverage; increasing cases led to an intensive door-to-door re-
peat vaccination campaign in high-risk areas of the city. Cases
decreased sharply after the door-to-door campaign. However,
occasional cases of measles continued to be reported until
a nationwide door-to-door campaign was conducted in mid-
2001. This outbreak highlights the effectiveness of focused, well-
supervised campaigns, the futility of poorly run activities, and
the need to cover a geographic area beyond which the outbreak
was occurring [39].
Outbreaks followed by ORI were also described in Venezuela,
Colombia [40, 41], Chile [42], and Argentina [43, 44]. Despite
measles vaccination coverage of only 58% in 2001, Venezuela
was able to stop an outbreak of 37 cases from growing by
conducting a statewide ORI for children aged 1–14 years; cov-
erage for this ORI was not reported. Later in the same year, it
attempted to contain another outbreak with a nationwide
campaign targeting children aged 1–4 years; many pockets were
missed, and the outbreak expanded to 2397 cases before being
stopped by another nationwide campaign, this one targeting
children aged 1–14 years and adults at high risk and reported
to have achieved .100% coverage. The outbreak spread to
Colombia. With routine coverage .78%, Colombia was able to
stopongoing transmission after 139caseswerereportedthrough
a nationwide campaign targeting children aged 6 months to 5
yearsandadults athighrisk. SimilartoColombia, Chilewasable
to contain its outbreak to 19 cases of measles, reportedly due to
a combination of high background immunity and a commu-
nity-wide vaccination program.
One article also describes a Peruvian outbreak [45] that oc-
curred from 22 July through 21 September 1993 in a remote,
sparselypopulatedvillage.Thisserologicallyconﬁrmedoutbreak
was the ﬁrst in 20 years despite a lack of routine vaccination
servicesandpoorcoverage (,10%)duringoutreachactivities.It
affected 27% of the population in the area, with 44% of cases in
adults aged 16–40 years. ORI targeting children aged 6 months
to 15 years was conducted 35 days after onset of illness in the
index patient. Only 2 cases occurred R2 weeks after ORI, and
both of these were in children aged ,6 months. The large inter-
household distances may have helped ORI to be effective despite
the presence of susceptibility to measles in older age groups.
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 African Region
Soula et al [46] described an outbreak in Houet, a province of
Burkina Faso with measles vaccine coverage of 50%. This epi-
demic lasted from October 1995 through May 1996, with most
cases occurring after January 1996. Fifty-eight percent of cases
wereinchildrenaged,5years.Theoutbreakwasnotedtobegin
in 2 suburban and 1 central starter zones in Bobo Dioulasso but
did not spread rapidly until it reached high population density
areas in the third week of January. Beginning in April, 95% of
children in daycare centers and primary school were vaccinated.
The authors comment that ORI was conducted late after out-
break detection and that the target age group appeared to be
inappropriate because of the age distribution of cases; they do
not comment on the effect of the vaccination activities, although
the epidemic curve appears to show impact [46].
AnoutbreakinNiamey,Niger,wasreportedbyGraisetal[13,
47, 48, 49] and Dubray et al [50]. The campaign, targeting all
children aged 6–59 months, began 23 weeks after outbreak onset
and reached 57% of the targeted population. Dubray’s epidemic
curve shows a decrease of 50% in cases beginning 2 weeks after
ORI. Grais et al used mathematical modeling to assess the
number of averted cases and the difference that would have been
made had the target age group been expanded to children aged 6
months to 15 years or had the campaign begun earlier. These
analyses showed that timely implementation of ORI could result
in substantial numbers of cases averted and that the proportion
of cases averted was associated both with coverage achieved and
the number of birth cohorts targeted in the ORI. The authors
conclude that more cases can be averted through early in-
tervention targeting a wide age range even if vaccination cov-
erage is low, compared with the number of cases that can be
averted through higher coverage with a later intervention.
Vaccination response was mentioned in articles on Zimbabwe
[51] and Kenya [21]; however, the impact of these activities was
not described.
Southeast Asian Region
Puvimanisinghe et al [52] summarized an explosive measles
epidemic of .15,000 suspected cases experienced in Sri Lanka
during 1999–2001. Nationwide, background coverage with 1
dose of measles vaccine was high at 90%. In response to the
outbreak, vaccination was offered to children aged ,10
years without evidence of vaccination; in addition, an extra
dose of vaccine was administered to all children in welfare
centers, refugee camps, preschools, and urban slums. However,
Puvimanisinghe et al [52] does not discuss the impact of these
vaccination activities, nor can it be easily deduced from the
epidemiccurve.Thakuretal[53]andRathoetal[54]reported2
measles outbreaks with ORI in India. Thakur et al describes
response immunization for children aged ,5 years in a focused
geographic area in December 1998, with persistent measles cases
reported in January 1999. Proximal areas did not conduct
vaccination activities and reported new measles cases in Feb-
ruary. Ratho et al mentions ORI but does not discuss impact.
Mohan et al [55] described measles transmission after the
2004 tsunami in India. A cluster of cases occurred in tsunami-
affected and unaffected villages, and supplementary immuni-
zation activities targeting children aged 6–60 months were
conducted in tsunami-affected areas. These SIAs were in re-
sponse to the emergency rather than the outbreak. Their timing
relative to the reporting of the ﬁrst measles case is not clear.
Tsunami-affected areas showed lower measles incidence than
non-tsunami areas; however, measles transmission persisted
longer in these areas.
European Region
Three articles reported outbreakswith ORI (Marinova et al[56],
Seguliev et al [57], and Ceylan et al [58]). However, the impact
of these activities was not described.
DISCUSSION
This article reviews data published during 1995–2009 to sys-
tematically examine the potential impact of measles vaccination
campaigns in response to measles outbreaks. Various ap-
proaches to examining impact of vaccination activities were
used by the articles that we reviewed, including length of out-
break [25],, persistence of measles after immunization activities
both locally and nationally [26, 37, 39, 45], shape of epidemic
curve [34], measles cases prevented [45], and preventable frac-
tion [33]. Although some articles presented clear evidence of the
impact of ORI, in others, available data were more difﬁcult to
interpret or were inadequate to permit objective evaluation. As
in the case of Darfur, a high-coverage, wide–age-range vacci-
nation campaign may have an impact easily detected in the
epidemic curve [34]; delay in implementing or more prolonged
delivery of vaccine, as in the Marshall Islands, may have a much
less obvious impact [28]. Vaccination may also be offered when
the reported number of cases is already decreasing, as in the
Burkina Faso report [46], leading to difﬁculty determining the
relative contributions of immunization and the exhaustion of
remaining susceptible persons due to acquisition of measles.
Measles outbreaks eventually burn out when most susceptible
persons are exhausted; when ORI is conducted late in isolated
communities or in those with high background vaccination
coverage, ORI may appear to be successful when, in fact, the
outbreak would have ended even without it.
Most of the outbreak responses that we considered to have
demonstrated impact were nonselective, with the sole exception
being that in the Marshall Islands. However, the self-contained
nature of these small islands, access to records from several
sources, and the multiple rounds of immunization may have
ensured that, in this setting, unvaccinated individuals were not
accidentally missed.
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 These reports highlight the variable beneﬁts and challenges of
ORI and emphasize the importance of considering a variety of
outbreak-speciﬁc factors in determining whether to conduct
ORI, including the country’s measles control goals, background
vaccination coverage, age distribution of cases, population
movement,populationdensity,case-fatality ratios,and ability to
conduct a timely response. The Americas, a region with a mea-
sles elimination goal, has taken an especially aggressiveapproach
toORI.The Haitian experienceemphasizes boththesuccess that
a well-conducted and planned ORI may have in stopping
transmission locally, as in Gonaı ¨ves, and the challenges of
stopping disease spread to other regions when background
vaccination coverage is low [39]. The challenge of achieving
populationimpactwithORI insettingsoflowcoveragerecursin
the reports from Bolivia and Venezuela [37, 40].
Papers from Peru and the Marshall Islands indicate the rela-
tionships of population density, target population, and the
success of ORI. Both the Peruvian village and the Marshall Is-
lands had populations too small to sustain endemic disease;
isolation had, in both cases, resulted in many measles-free years
despite extensive population susceptibility. Although 44% of all
Peruvian cases were in those aged .15 years, a high-coverage
ORI targeting only children aged 6 months to 15 years stopped
the outbreak. However, in the Marshall Islands, with a similar
proportion of older cases, transmission was not stopped until
vaccination was extendedtothose aged ,40years. The Peruvian
village had exceptionally low population density, whereas that of
Majuro was very high at 6692 persons/mi
2 [28, 45].
Guris et al [25] demonstrated the association between time to
vaccinate 80% of the target population and length of outbreak.
Similarly, Al-Wahaibi et al [33] found a strong association be-
tween time to achieve full vaccination of a school and pre-
ventable fraction of cases. Grais et al [47] also emphasized the
importance of timely vaccination in concluding that more cases
could be averted through early intervention targeting a wide age
range, even if vaccination coverage is lower than can be averted
through higher coverage with a later intervention.
Grais et al [13] was also able to document the persistence of
measles outbreaks in Kinshasa for .20 weeks in the absence of
ORI. In this city, a measles epidemic lasted .16 weeks before it
reached certain neighborhoods. The authors speculate that slow
spread of disease may have been attributable to limited internal
mobility and a lower-than-expected effective reproductive ratio
(The effective reproductive ratio is the average number of sec-
ondary cases resulting from a single infectious individual in
a partially immunized population). These data suggest that,
because of the length of outbreaks in the absence of ORI, even
delayed vaccination could have an impact.
In some cases (eg, the report by Thakur et al [53] of ORI in
India), response was limited to the directly affected population.
In others, such as ORI reported from Bolivia and Venezuela
[37, 40] and from Sudan [34], ORI targeted a much broader
geographic area. Epidemiologic considerations would suggest
that the latter approach would be successful; this appears to be
borne out in the literature.
Paradoxically, the low-coverage settings where ORI may be
least likely to stop transmission are the environments where it
may offer greatest beneﬁt. Because of the high percentage of
persons susceptible to measles in such settings, each ORI
dose delivered has a much higher chance of producing needed
immunity than in a high-coverage population where most in-
dividuals are already immune. Historically, settings where high
background coverage existed tended to be those where the
greatest political will to conduct ORI was greatest, as in Mexico
[35, 36]. Recent investments in nationwide catch-up campaigns
in Africa and Asia and increases in routine coverage could
therefore raise the proﬁle of subsequent measles outbreaks and
increase the political pressure to conduct ORI.
The articles that we summarize report the occurrence of
measles outbreaks and corresponding ORI. However, they did
not report on such critical issues as government funding for
measles control, priority given to outbreak response, trained
personnel available and mobilized, and ready availability of
vaccine,syringes,andcoldchain equipment.Inmost cases,these
are reﬂected in the time elapsed between outbreak detection and
ORI and clearly play a critical role in the success of ORI.
Our study was limited by inability to obtain a small per-
centage of papers identiﬁed through our literature search. In
addition, it is possible that manuscripts showing a positive
impact of ORI were more likely to be published than were those
that did not. The articles reviewed presented data from such
divergent settings as hospitals and community-based inves-
tigations, as well as using disparate methods of documenting the
impact of ORI, thus making comparisons between outbreaks
difﬁcult. Finally, because few relevant papers providing insight
into the impact of ORI were found from the European or
SouthEast Asian Regions, our ﬁndings are based predominantly
on experiences in the Western Paciﬁc, Eastern Mediterranean,
American, and African Regions.
CONCLUSIONS
Thearticlesthatwereviewedgenerallydemonstrateadecreasein
morbidity associated with ORI and document the impact ach-
ieved by rapidly reaching high coverage in the population tar-
geted. They reveal the difﬁculty of preventing spread to other
geographic areas and emphasize the importance of considering
age distribution of cases, potential timeliness of ORI, population
density, and population movement in planning a vaccination
response. Furthermore, the recent outbreaks described demon-
strate that epidemics may last months in limited geographic
areas and that spread of disease may be especially slow in areas
with little population movement and low disease reproductive
ratio. This is contrary to previous assumptions that, after
S44 d JID 2011:204 (Suppl 1) d Cairns et al
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 a measles outbreak is detected in a population with low mea-
sles immunity, it is too late to implement ORI because of the
rapid spread of disease. Many reports did not provide sufﬁcient
information to allow us to judge the impact of ORI. Nonethe-
less, in 16 (42%) of 38 outbreaks in which ORI was used,
we believe that there was substantial evidence that ORI had
a clear impact.
These ﬁndings generally support use of ORI in middle- and
low-income countries, particularly if ORI can be implemented
soon after outbreak detection. However, considerations such as
limited availability of funds, vaccine, syringes, and vaccinators
may present serious logistical constraints to conducting high-
coverage ORI, particularly in wide geographic areas. For these
reasons, the decision to conduct an ORI and the nature and
extent of vaccination response still needs to be made on a case-
by-casebasis,takingintoaccountepidemiologic andoperational
factors. To support countries in rapidly implementing ORI, as is
currently recommended, the global measles community should
consider outbreak preparedness, response planning, and fund
raising. Whether immunizationis conducted, outbreakresponse
should include enhanced surveillance, efforts to limit case con-
tact withsusceptible persons, and case management,particularly
treatment with vitamin A. Finally, although outbreak response
immunization can be effective in controlling measles outbreaks,
the best and most cost-effective approach to outbreak control is
the primary prevention of epidemics entirely by ensuring high
coverage with 2 doses of measles vaccine for all children [19].
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